Qingdao Haier Biomedical Co Ltd (688139) — Capital Reinvestment Ratio
Qingdao Haier Biomedical Co Ltd (688139) has a Capital Reinvestment Ratio of 7.36x as of June 2023, meaning it reinvests 7% of its operating cash flow (CN¥7.33 Million) in capital expenditures (CN¥53.93 Million). Check how tangible is Qingdao Haier Biomedical Co Ltd's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Qingdao Haier Biomedical Co Ltd Capital Reinvestment Ratio (2016–2025)
This chart tracks Qingdao Haier Biomedical Co Ltd's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see Qingdao Haier Biomedical Co Ltd operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Qingdao Haier Biomedical Co Ltd (2016–2025)
Year-by-year Capital Reinvestment Ratio for Qingdao Haier Biomedical Co Ltd from 2016 to 2025. See Qingdao Haier Biomedical Co Ltd (688139) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | CN¥267.89 Million | CN¥119.25 Million | ▲ +2.5% |
| 2024 | 0.43x | CN¥291.67 Million | CN¥126.70 Million | ▼ -38.9% |
| 2023 | 0.71x | CN¥249.26 Million | CN¥177.18 Million | ▲ +52.8% |
| 2022 | 0.47x | CN¥632.43 Million | CN¥294.24 Million | ▲ +43.8% |
| 2021 | 0.32x | CN¥632.43 Million | CN¥204.69 Million | ▲ +153.4% |
| 2020 | 0.13x | CN¥696.62 Million | CN¥88.99 Million | ▼ -78.7% |
| 2019 | 0.60x | CN¥280.49 Million | CN¥168.40 Million | ▲ +29.0% |
| 2018 | 0.47x | CN¥149.00 Million | CN¥69.33 Million | ▲ +155.8% |
| 2017 | 0.18x | CN¥148.32 Million | CN¥26.98 Million | ▲ +176.8% |
| 2016 | 0.07x | CN¥220.72 Million | CN¥14.50 Million | — |